PIK3CA and ductal breast carcinoma in situ: PIK3CA mutations were slightly more common in non‐recurrent DCIS than in DCIS with clonal recurrences but this was not statistically significantly different (p = 0.068, Fisher's exact test; supplementary material, Figure S16).